Key facts
- This page summarizes WEXFORD CAPITAL LP's Form 4 filing for NEPHROS INC (NEPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2024, 16:43.
WEXFORD CAPITAL LP - 13 Mar 2024 Form 4 Insider Report for NEPHROS INC (NEPH)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- NEPH
- Reported as of
- 13 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2024, 16:43:14 UTC
- Prior SEC filing
- 14 Mar 2024
- Next SEC filing
- 22 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- Wexford Capital LP, By: Wexford GP LLC, its general partner, By: Daniel J. Weiner, Vice President and Assistant Secretary
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
WEXFORD CAPITAL LP filed Form 4 for NEPHROS INC (NEPH) on 14 Mar 2024.
Change
- Previous filing in this sequence was filed on 14 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEPH
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -91,463
- Change %
- -62%
- Price
- $0.000000
- Shares after
- 56,060
- Date
- 13 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
NEPH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,544,492
- Date
- 13 Mar 2024
- Ownership
- See footnotes
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents an in-kind distribution by Wexford Capital LP ("Wexford Capital") to Arthur Amron that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration, in connection with his separation from service as an employee of Wexford Capital.
Footnote F2
Represents the common stock of the Issuer held in the aggregate by Wexford Spectrum Trading Limited ("WST"), Wexford Partners 11, L.P., ("WP11"), WPIC 2 LLC ("WPIC2", and together with WST and WP11, the "Wexford Entities") and Wexford 11 Advisors LLC ("Wexford Advisors").
Footnote F3
Wexford Capital may, by reason of its status as (i) sub-advisor of WST, (ii) investment manager of WP11 and (iii) manager of WPIC2, be deemed to own beneficially the securities held by the Wexford Entities. Wexford GP LLC ("Wexford GP") may, as the General Partner of Wexford Capital, be deemed to own beneficially the securities held by the Wexford Entities. Each of Charles E. Davidson ("Davidson") and Joseph M. Jacobs ("Jacobs", and together with Wexford Capital, Wexford GP and Davidson, the "Reporting Persons") may, by reason of his status as a controlling person of Wexford GP and Wexford Advisors, be deemed to own beneficially the securities held by the Wexford Entities and Wexford Advisors.
Footnote F4
Each of Wexford Capital, Wexford GP, Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by the Wexford Entities. Each of Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by Wexford Advisors. Each of Wexford Capital, Wexford GP, Davidson and Jacobs disclaim beneficial ownership of the securities owned by the Wexford Entities and/or Wexford Advisors, as applicable, and this report shall not be deemed as an admission that they are the beneficial owners of such securities, except to the extent of any pecuniary interests therein.